johnson controls international plc - JCI
JCI
Close Chg Chg %
114.21 0.00 0.00%
Closed Market
114.21
0.00 (0.00%)
Volume: 4.47M
Last Updated:
Dec 4, 2025, 3:59 PM EDT
Company Overview: johnson controls international plc - JCI
JCI Key Data
| Open $113.48 | Day Range 113.00 - 115.16 |
| 52 Week Range 68.03 - 123.78 | Market Cap $69.80B |
| Shares Outstanding 611.14M | Public Float 609.35M |
| Beta 1.42 | Rev. Per Employee N/A |
| P/E Ratio 22.91 | EPS $5.11 |
| Yield 130.99% | Dividend $0.40 |
| EX-DIVIDEND DATE Sep 22, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 5.13M |
JCI Performance
| 1 Week | -1.81% | ||
| 1 Month | -6.58% | ||
| 3 Months | 7.50% | ||
| 1 Year | 35.40% | ||
| 5 Years | 148.86% |
JCI Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
23
Full Ratings ➔
About johnson controls international plc - JCI
Johnson Controls International Plc engages in the provision of building products, energy solutions, integrated infrastructure and next generation transportation systems. Its products and solutions include fire detection and suppression, security, HVAC equipment, building automation and controls, digital, industrial refrigeration, residential and smart home, retail, distributed energy storage, and batteries. The company was established in 1885 and is headquartered in Cork, Ireland.
JCI At a Glance
Johnson Controls International Plc
1 Albert Quay
Cork, Cork T12 X8N6
| Phone | 353-21-423-5000 | Revenue | 23.60B | |
| Industry | Industrial Machinery | Net Income | 3.29B | |
| Sector | Producer Manufacturing | 2025 Sales Growth | 2.806% | |
| Fiscal Year-end | 09 / 2026 | Employees | 87,000 | |
| View SEC Filings |
JCI Valuation
| P/E Current | 22.913 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 21.853 |
| Price to Sales Ratio | 3.048 |
| Price to Book Ratio | 5.198 |
| Price to Cash Flow Ratio | 51.41 |
| Enterprise Value to EBITDA | 22.493 |
| Enterprise Value to Sales | 3.507 |
| Total Debt to Enterprise Value | 0.135 |
JCI Efficiency
| Revenue/Employee | 271,218.391 |
| Income Per Employee | 37,827.586 |
| Receivables Turnover | 3.762 |
| Total Asset Turnover | 0.585 |
JCI Liquidity
| Current Ratio | 0.899 |
| Quick Ratio | 0.733 |
| Cash Ratio | 0.035 |
JCI Profitability
| Gross Margin | 36.366 |
| Operating Margin | 11.926 |
| Pretax Margin | 8.345 |
| Net Margin | 13.947 |
| Return on Assets | 4.269 |
| Return on Equity | 11.859 |
| Return on Total Capital | 7.136 |
| Return on Invested Capital | 7.227 |
JCI Capital Structure
| Total Debt to Total Equity | 86.563 |
| Total Debt to Total Capital | 46.399 |
| Total Debt to Total Assets | 29.495 |
| Long-Term Debt to Equity | 74.843 |
| Long-Term Debt to Total Capital | 40.117 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Johnson Controls International Plc - JCI
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 25.30B | 26.79B | 22.95B | 23.60B | |
Sales Growth
| +6.89% | +5.91% | -14.34% | +2.81% | |
Cost of Goods Sold (COGS) incl D&A
| 16.98B | 17.79B | 14.87B | 15.02B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 830.00M | 848.00M | 816.00M | 865.00M | |
Depreciation
| 403.00M | 409.00M | 340.00M | 426.00M | |
Amortization of Intangibles
| 427.00M | 439.00M | 476.00M | 439.00M | |
COGS Growth
| +8.75% | +4.77% | -16.43% | +0.97% | |
Gross Income
| 8.31B | 9.00B | 8.08B | 8.58B | |
Gross Income Growth
| +3.28% | +8.23% | -10.20% | +6.19% | |
Gross Profit Margin
| +32.87% | +33.59% | +35.21% | +36.37% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 5.94B | 6.18B | 5.66B | 5.77B | |
Research & Development
| 295.00M | 320.00M | 267.00M | 273.00M | |
Other SG&A
| 5.64B | 5.86B | 5.39B | 5.49B | |
SGA Growth
| +12.41% | +4.06% | -8.43% | +1.89% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 631.00M | 1.16B | 448.00M | 634.00M | |
EBIT after Unusual Expense
| 1.74B | 1.66B | 1.97B | 2.18B | |
Non Operating Income/Expense
| 303.00M | 306.00M | 11.00M | (54.00M) | |
Non-Operating Interest Income
| 6.00M | 18.00M | 17.00M | 19.00M | |
Equity in Earnings of Affiliates
| 246.00M | 265.00M | (42.00M) | 6.00M | |
Interest Expense
| 337.00M | 257.00M | 462.00M | 157.00M | |
Interest Expense Growth
| -19.38% | -23.74% | +79.77% | -66.02% | |
Gross Interest Expense
| 337.00M | 257.00M | 462.00M | 157.00M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 1.71B | 1.71B | 1.52B | 1.97B | |
Pretax Income Growth
| - | -34.58% | -10.99% | +29.37% | |
Pretax Margin
| +6.76% | +6.38% | +6.63% | +8.34% | |
Income Tax
| (13.00M) | (323.00M) | 111.00M | 245.00M | |
Income Tax - Current - Domestic
| (166.00M) | (60.00M) | 416.00M | (251.00M) | |
Income Tax - Current - Foreign
| 294.00M | 413.00M | 102.00M | 302.00M | |
Income Tax - Deferred - Domestic
| (244.00M) | (292.00M) | (325.00M) | 464.00M | |
Income Tax - Deferred - Foreign
| 103.00M | (384.00M) | (82.00M) | (270.00M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 246.00M | 265.00M | (42.00M) | 6.00M | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 1.72B | 2.03B | 1.41B | 1.72B | |
Minority Interest Expense
| 191.00M | 184.00M | 4.00M | 3.00M | |
Net Income
| 1.53B | 1.85B | 1.41B | 1.72B | |
Net Income Growth
| +1.26% | +20.69% | -23.90% | +22.32% | |
Net Margin Growth
| +6.06% | +6.90% | +6.13% | +7.29% | |
Extraordinaries & Discontinued Operations
| - | - | 298.00M | 1.57B | - |
Discontinued Operations
| - | - | 298.00M | 1.57B | - |
Net Income After Extraordinaries
| 1.53B | 1.85B | 1.71B | 3.29B | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 1.53B | 1.85B | 1.71B | 3.29B | |
EPS (Basic)
| 2.2008 | 2.702 | 2.5304 | 5.0491 | |
EPS (Basic) Growth
| -3.66% | +22.77% | -6.35% | +99.54% | |
Basic Shares Outstanding
| 696.10M | 684.30M | 673.80M | 651.80M | |
EPS (Diluted)
| 2.1898 | 2.6898 | 2.5222 | 5.0313 | |
EPS (Diluted) Growth
| -3.54% | +22.83% | -6.23% | +99.48% | |
Diluted Shares Outstanding
| 699.60M | 687.40M | 676.00M | 654.10M | |
EBITDA
| 3.21B | 3.67B | 3.24B | 3.68B | |
EBITDA Growth
| -11.27% | +14.38% | -11.70% | +13.65% | |
EBITDA Margin
| +12.67% | +13.68% | +14.10% | +15.59% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 132.059 | |
| Number of Ratings | 23 | Current Quarters Estimate | 0.835 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 4.579 | |
| Last Quarter’s Earnings | 1.26 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 3.76 | Next Fiscal Year Estimate | 5.337 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 18 | 18 | 20 | 18 |
| Mean Estimate | 0.83 | 1.04 | 4.58 | 5.34 |
| High Estimates | 0.86 | 1.07 | 4.70 | 5.67 |
| Low Estimate | 0.80 | 1.01 | 4.44 | 5.15 |
| Coefficient of Variance | 1.70 | 1.44 | 1.40 | 2.55 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 11 | 11 | 11 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 11 | 11 | 10 |
| UNDERWEIGHT | 0 | 0 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Johnson Controls International Plc - JCI
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Johnson Controls International Plc - JCI
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Nov 26, 2025 | Lei Zhang Schlitz VP & Pres, Global Products | 66,781 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $113.2 per share | 7,559,609.20 |
| Apr 2, 2025 | Nathan D. Manning VP, President BSNA | 145,502 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $79.72 per share | 11,599,419.44 |
| Mar 17, 2025 | Patrick K. Decker Director | 3,104 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $78.68 per share | 244,222.72 |
| Mar 17, 2025 | Timothy M. Archer Director | 5,661 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | George R. Oliver Director | 1,003,893 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $77.49 per share | 77,791,668.57 |
| Mar 17, 2025 | Marc Vandiepenbeeck EVP and CFO | 152,184 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.68 per share | 11,973,837.12 |
| Mar 17, 2025 | George R. Oliver Director | 1,119,562 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $79.52 per share | 89,027,570.24 |
| Mar 17, 2025 | John D. Young Director | 16,829 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $78.68 per share | 1,324,105.72 |
| Mar 17, 2025 | John D. Young Director | 18,245 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Gretchen R. Haggerty Director | 22,497 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $78.68 per share | 1,770,063.96 |
| Mar 17, 2025 | Gretchen R. Haggerty Director | 23,913 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Jean Stuart Blackwell Director | 16,243 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Patrick K. Decker Director | 3,859 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Joakim Weidemanis Chief Executive Officer | 107,342 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Joakim Weidemanis Chief Executive Officer | 53,671 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Joakim Weidemanis Chief Executive Officer | 31,774 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.68 per share | 2,499,978.32 |
| Mar 17, 2025 | Webster Roy Dunbar Director | 17,141 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $78.68 per share | 1,348,653.88 |
| Mar 17, 2025 | Webster Roy Dunbar Director | 18,557 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Pierre Eric Cohade Director | 13,672 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $78.68 per share | 1,075,712.96 |
| Mar 17, 2025 | Pierre Eric Cohade Director | 15,088 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |